Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, I... (lty streams atcompetitive rates from com...)

Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)

Date:8/27/2007

lty streams at competitive rates from companies, institutions and inventors. DRC is a leader in monetizing royalties, having acquired over $850 million in royalty-based cash flows on commercialized products.

Its Structured Finance Fund will soon close with approximately $300 million in committed capital. This Fund provides predominantly non-dilutive financing for product acquisitions and launches, M & A, in-licensing, sales force expansion and general working capital purposes to companies within the healthcare industry. The Fund invests in cash flow monetization structures which can include debt and equity components, custom tailored to fit the needs of clients.

About Enzon (ENZN)

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development, manufacturing, commercialization of important medicines for patients with cancer and other life-threatening conditions. Enzon has a portfolio of four marketed products, Oncaspar(R), DepoCyt(R), Abelcet(R) and Adagen(R). The Company's drug development programs utilize several cutting- edge approaches, including its industry-leading PEGylation technology platform used to create product candidates with benefits such as reduced dosing frequency and less toxicity. Enzon's PEGylation technology was used to develop two of its products, Oncaspar and Adagen, and has created a royalty revenue stream from licensing partnerships for other products developed using the technology. Enzon also engages in contract manufacturing for several pharmaceutical companies to broaden the Company's revenue base. Further information about Enzon can be found on the Company's web site at http://www.enzon.com.

SOURCE Drug Royalty Corporation, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Trouble-shooting: Misincorporation or low fidelity
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. Promega Corporation: Wisconsins quiet innovator
5. Giuliani will keynote RedPrairie Corporations user conference
6. Madison Development Corporation makes loans to three area companies
7. Corporations and blogging
8. Metavante acquires Florida banking corporation
9. TriMas Corporations Cequent Group Acquires Chem-Chrome, Inc.
10. Speaker announces business members of IT Task Force
11. Doyle announces technology tax credits for Berbee

Post Your Comments:

(Date:12/2/2009)The Scientist, a leading scientific magazine covering the life sciences, ranked Photometrics’ Evolve “Intelligent” EMCCD camera fourth among the publication’s “Top 10 Inn

(Date:12/1/2009)Dr. Kerry Solomon announced that he has joined Carolina Eyecare Physicians and has launched his redesigned website at www.DrKerrySolomon.com , which was developed by Medical Consulting Group. Dr. So

(Date:12/1/2009)NEW YORK, Dec. 1 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Chromium - Global Market Trends ,, http://www.reportlinker.com/p0164494/Chromium--

(Date:12/1/2009)NEW YORK, Dec. 1 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Emerging Clinical Trial Locations - Eastern Europe: Market dynamics and the changing h

Breaking Biology Technology:The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2 The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3 Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2 Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3 Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4 Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5 Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6 Reportlinker Adds Chromium - Global Market Trends 2 Reportlinker Adds Chromium - Global Market Trends 3 Reportlinker Adds Chromium - Global Market Trends 4 Reportlinker Adds Chromium - Global Market Trends 5 Reportlinker Adds Chromium - Global Market Trends 6 Reportlinker Adds Chromium - Global Market Trends 7 Reportlinker Adds Chromium - Global Market Trends 8 Reportlinker Adds Chromium - Global Market Trends 9 Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2 Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3 Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4 Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5 Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6 Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7 Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8

[0] The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 [0] Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com [0] Reportlinker Adds Chromium - Global Market Trends [0] Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment

...N.J. and EMERYVILLE, Calif., May 14 Bayer HealthC..., Inc. (Nasdaq: ONXX ) today announced that more...(sorafenib) tablets will be presented at the 2009 ...l meeting. , , "Nexavar has a proven track record... hepatocellular carcinoma (HCC), or liver cancer, ...

..., May 14 ANY LAB TEST NOW(R), the first retail di...ations nationwide, has partnered with Atherotech, ...to provide the VAP(R) Cholesterol Test direct to c...ol Test is an expanded cholesterol profile that id... the first cholesterol test to directly measure LD...

...LE, Md., May 14 Vanda Pharmaceuticals Inc. (Nasda...osters on its newly approved atypical antipsychoti... Psychiatric Association (APA) annual meeting in S... for the acute treatment of schizophrenia in adult...teon at APA. Tasimelteon is an investigational co...

Other Biology Technology:Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 2 Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 3 Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 4 Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 5 Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 6 VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R) 2 VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R) 3 Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting 2 Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting 3 Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting 4

Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R)Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting

(Date:12/3/2009)WALL, N.J., Dec. 3 BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, announced that a majority of its sha

(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo

(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re

Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2 BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3 A window that washes itself? 2 VAI researchers find long awaited key to creating drought resistant crops 2 VAI researchers find long awaited key to creating drought resistant crops 3 Consumer Reports Health News August 2009 55382 1 Consumer Reports Health News August 2009 55382 2 Consumer Reports Health News August 2009 55382 3 Consumer Reports Health News August 2009 55382 4 Trans Ionics Announces New Service Custom Separation Synthesis 28CSS 29 28TM 29 55378 1 Trans Ionics Announces New Service Custom Separation Synthesis 28CSS 29 28TM 29 55378 2 Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 1 Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 2 Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 3 Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 4

[0] BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division [0] A window that washes itself?[0] VAI researchers find long awaited key to creating drought resistant crops

...entists have identified one of the genes implicate...mmon cause of blindness in developed countries. , ...et , adds to the growing understanding of the gene...ich the researchers believe should ultimately lead...o-thirds of people aged 80 years or older are affe...

...versity of Iowa researchers and colleagues in Fran...tentially fatal human heart rhythm disorder called...drome," the disease affects approximately one in 6... for 50 percent or more of the permanent pacemaker...wly discovered gene variant is rare, the study pro...

... atomic-resolution view of an enzyme found only in...f Washington (UW) clues about how this enzyme, ess...odiesterase 6 (PDE6), is central to the way light ... signals to the brain. , This particular form of...the retina and has not been well-researched, in co...

Other Biology News:Genetic finding implicates innate immune system in major cause of blindness 2 Study provides insight on a common heart rhythm disorder 2 Study provides insight on a common heart rhythm disorder 3 Atomic-resolution views suggest function of enzyme that regulates light-detecting signals in eye 2

Genetic finding implicates innate immune system in major cause of blindness Study provides insight on a common heart rhythm disorder Atomic-resolution views suggest function of enzyme that regulates light-detecting signals in eye

SURE E. coli Strain from Stratagene

21-mer duplex from B-Bridge International

...dy to CRF The antibody blocks specificially with ... Cells and fibres are found in the paraventricular...reated 4% FA perfused tissue. Immunogen: CRF: ...s-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-...

JM101 E. coli Strain from Stratagene

Biology Products:

SURE E. coli Strain from Stratagene 21-mer duplex from B-Bridge International Rabbit Anti-CRF Polyclonal Antibody, Unconjugated from GeneTex JM101 E. coli Strain from Stratagene

Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, I...(lty streams atcompetitive rates from com...)